Table 3.
Solute | Model 1 |
Model 2 |
|||
---|---|---|---|---|---|
Relative difference in uACR (95% CI) | P-value | Relative difference in uACR (95% CI) | P-value | ||
Cinnamoylglycine | 0.99 (0.88, 1.12) | 0.89 | 1.00 (0.89, 1.12) | 0.96 | |
Isovalerylglycine | 1.11 (0.95, 1.30) | 0.19 | 1.15 (0.99, 1.34) | 0.07 | |
Kynurenic acid | 1.18 (0.98, 1.42) | 0.08 | 1.18 (0.98, 1.42) | 0.08 | |
P-cresol sulfate | 1.08 (0.96, 1.21) | 0.19 | 1.10 (0.98, 1.23) | 0.09 | |
Xanthosine | 1.13 (1.00, 1.28) | 0.05 | 1.11 (0.98, 1.26) | 0.09 | |
Summary score | 1.12 (1.00, 1.25) | 0.06 | 1.13 (1.00, 1.27) | 0.046a |
CI, confidence interval; SBP, systolic blood pressure; uACR, urine albumin-to-creatinine ratio.
Entries are the ratio in geometric mean 10-year log-transformed urine albumin-to-creatinine ratio per 50% lower secretory clearance for individual solutes and per 10 point decrement for summary score. Model 1 adjusts for age, baseline estimated glomerular filtration rate, baseline log urine albumin-to-creatinine ratio, diabetes, flexibly modeled A1c, and sex; model 2 further adjusts for SBP, body mass index, and current smoking.
Significant at P < 0.05.